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Abstract The stress response enzyme heme oxygenase (HO)-1
is induced in livers of selenium-de¢cient rodents, probably to
compensate for loss of certain selenoproteins. We sought to
identify those selenoproteins. Selenium-replete mice with genetic
deletion of selenoprotein P or glutathione peroxidase-1 did not
have elevated hepatic HO activity, thus ruling out involvement
of those selenoproteins in HO-1 induction by selenium de¢-
ciency. However, inhibition of thioredoxin reductase (TrxR)
by a low dose of gold in the form of aurothioglucose led to
induction of hepatic HO activity. Moreover, further induction
by phenobarbital was observed. This HO-1 induction pattern
is also seen in selenium-de¢cient mice. In the rat hepatoma
cell line H4IIE, inhibition of TrxR by aurothioglucose or by
1-chloro-2,4-dinitrobenzene led to induction of HO-1. We con-
clude that loss of TrxR is responsible for the induction of HO-1
by selenium de¢ciency.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Dietary selenium de¢ciency causes a decrease in selenopro-
teins, some of which have oxidant defense functions. This loss
of antioxidant activity in selenium de¢ciency is accompanied
by increased activities of several stress response enzymes that
are not selenium-dependent. NAD(P)H:quinone reductase,
glutathione S-transferase, Q-glutamyl-cysteine synthetase, and
heme oxygenase (HO)-1 are two- to three-fold up-regulated in
selenium-de¢cient rodent livers compared with selenium-re-
plete controls [1^5]. These up-regulated enzymes have been
associated with defense against oxidative stress.
In an earlier study we showed that HO-1 is expressed in
selenium-de¢cient hepatocytes but not in control hepatocytes
[5]. Moreover, the housekeeping heme oxygenase isoform
HO-2 was unchanged in selenium-de¢cient hepatocytes. We
reasoned that the activity of the induced HO-1 was likely to
be compensating for an antioxidant function of a selenoprotein
that was decreased in the selenium-de¢cient liver. In order to
identify the selenoenzyme for which HO-1 compensates, we
carried out experiments in which individual selenoenzymes
were deleted or inhibited.
2. Materials and methods
2.1. Materials
All chemicals and enzymes were obtained from Sigma (St. Louis,
MO, USA) unless otherwise stated.
2.2. Animals and treatments
Male weanling C57BL/6 mice were fed either a control or a sele-
nium-de¢cient diet for 6 weeks following weaning (see [6] for diet
composition). In experiments with aurothioglucose (ATG), the com-
pound was dissolved in phosphate-bu¡ered saline (PBS, 2.5, 5, 10,
20 mg/ml) and administered i.p. (1 ml/100 g body weight). In experi-
ments with phenobarbital (PB), the compound was dissolved in 0.15 M
NaCl (8 mg/ml) and administered i.p. (1 ml/100 g body weight) 6 h
before the animal was killed. GSHPx-13=3 mice [7] were kindly pro-
vided by Dr. Y.S. Ho (Wayne State University, Detroit, MI, USA).
Generation and characteristics of Sepp3=3 (selenoprotein P knockout)
mice are described elsewhere [8]. Mice were killed by exsanguination
via the vena cava inferior under iso£urane anesthesia.
Livers were excised and homogenized in ice-cold 0.25 M sucrose,
100 mM potassium phosphate (pH 7.4), 1 mM phenylmethylsulfonyl
£uoride, 10 Wg/ml of each leupeptin and aprotinin. The homogenate
was centrifuged at 18 000Ug for 10 min at 4‡C and the supernatant
was used for HO assay.
2.3. Cell culture and treatment
The rat hepatoma cell line H4IIE was cultured in Dulbecco’s modi-
¢ed Eagle’s medium containing 2.5 g glucose per liter, non-essential
amino acids, penicillin-streptomycin, L-glutamine, 10% horse serum,
and 2.5% fetal calf serum. Cells were maintained at 37‡C under
5% CO2. ATG was dissolved in PBS, 1-chloro-2,4-dinitrobenzene
(CDNB) was dissolved in ethanol. Cells were treated for the indicated
length of time with graded amounts of thioredoxin reductase (TrxR)
inhibitors or an appropriate volume of the respective vehicle.
2.4. Assays
HO activity was measured spectrophotometrically in 18 000Ug
supernatants as described earlier [9]. Protein was determined using
the BCA protein assay kit (Pierce, Rockford, IL, USA). Cytosolic
glutathione peroxidase (GSHPx), phospholipid hydroperoxide gluta-
thione peroxidase (PH-GSHPx), glutathione reductase (GR) activities,
and cellular glutathione (GSH) levels were determined as previously
described [3,10^12]. TrxR activities were determined essentially as
described earlier [13].
2.5. Western blotting
Western detection of HO-1 protein was performed as described
elsewhere [5]. Polyclonal HO-1 antibodies were a kind gift from Dr.
C.D. Ferris (Vanderbilt University, Nashville, TN, USA).
2.6. Statistical analysis
Student’s t-test was performed using Microsoft Excel 98 (Microsoft,
Redmond, WA, USA).
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3. Results
3.1. Hepatic HO activity in selenoprotein de¢ciency
Fig. 1 compares the hepatic HO activities of control and
selenium-de¢cient mice with those of mice with speci¢c sele-
noproteins deleted. As observed in selenium-de¢cient rats [14],
selenium-de¢cient mice display hepatic HO activities twice as
high as selenium-replete control mice; PB treatment caused an
additional ¢ve-fold induction. In mice lacking either GSHPx-1
or selenoprotein P, hepatic HO activity was not elevated and
was not in£uenced by PB treatment. Thus, neither GSHPx-1
loss nor selenoprotein P loss is associated with HO-1 induc-
tion.
3.2. ATG inhibits TrxR and induces HO
Mice homozygous for disrupted selenoprotein P or GSHPx-
1 genes are the only animals with selenoprotein genes dis-
rupted that have been reported viable thus far. In order to
study the selenoenzyme TrxR, we resorted to inhibition of
TrxR with ATG. ATG inhibits both GSHPx and TrxR. How-
ever, its IC50 for GSHPx is three orders of magnitude greater
than for TrxR [15], indicating that TrxR can be inhibited with
a dose of ATG that would not inhibit GSHPx. Eight hours
following injection of mice with 100 mg ATG/kg, hepatic
cytosolic GSHPx and PH-GSHPx activities were not a¡ected,
while cytosolic TrxR activity was depressed to 3% of un-
treated control values (Fig. 2). GR, an enzyme structurally
and functionally related to TrxR, was also not inhibited by
this ATG dose.
The ATG treatment tripled HO activity in liver compared
to HO activity in livers of untreated mice (Table 1). Treat-
ment with PB 2 h after ATG treatment led to an additional
three-fold elevation in hepatic HO activity in ATG-treated
mice. Western analysis con¢rmed that both selenium de¢-
ciency and ATG treatment induced the expression of the
HO-1 isoform in the liver and enabled its further inducibility
by PB (Fig. 3). HO-1 had no appreciable expression in livers
of selenium-replete control mice that had not received ATG.
TrxR in murine liver exists in cytosolic (TrxR-1) and mito-
chondrial (TrxR-3) isoforms, although the former appears to
be more abundant than the latter [16]. Under the conditions
of the ATG experiment, TrxR activities in cytosolic and mi-
tochondrial fractions of mouse livers were equally inhibited
(data not shown).
3.3. Induction of HO-1 in rat hepatoma cells by ATG treatment
When rat hepatoma cells of the line H4IIE were treated
with graded amounts of ATG for 16 h, an IC50 of approx-
imately 25 Wg ATG/ml was observed for TrxR activity (Fig.
4). HO-1 expression level increased substantially when TrxR
activity fell below 4% of control activity. When ATG concen-
tration was raised above 1000 Wg/ml of medium, TrxR activity
became undetectable, but HO-1 protein continued to increase,
indicating that an induction mechanism independent of TrxR
inhibition might function at higher concentrations of ATG.
Fig. 1. HO activities in 18 000Ug liver supernatants from mice that
were untreated (empty bars) or treated with PB for 6 h (black
bars). Unless indicated (0Se), mice were fed a control diet contain-
ing 0.25 ppm selenium as sodium selenite. Mice were either wild-
type (wt) or homozygous gene knockout (k.o.) for the protein indi-
cated. Bars indicate meansPS.E.M., n=3^4.
Fig. 2. TrxR, GSHPx, PH-GSHPx and GR activities in 18 000Ug
liver supernatants from mice that were treated with ATG (100 mg/
kg b.w., 8 h, black bars) or left untreated (open bars). Bars indicate
meansPS.E.M., n=3.
Fig. 3. Representative Western detection of HO-1 in 18 000Ug liver
supernatants from mice that were untreated or treated with PB for
6 h. C and ATG mice were fed a control diet containing 0.25 ppm
selenium as sodium selenite. 0Se mice were selenium-de¢cient. The
ATG mice received ATG (100 mg/kg, i.p.) 8 h before being killed.
Where indicated, PB was given 2 h after ATG administration.
Table 1
HO activities in 18 000Ug liver supernatants from mice that were
fed diets containing the indicated amounts of selenium and treated
with PB (80 mg/kg b.w., i.p.) where indicated
Se (ppm) ATG (mg/kg b.w.) HO (pmol/mg/min)a
3PB +PB
0.25 0 4.2P 1.0a 3.8P 0.4a
0 0 9.0P 1.3b 44.4P 2.8c
0.25 100 13.2P 1.9b 41.9P 9.6c
aValues are meansPS.E.M., n=3^4. Values not sharing a common
superscript are signi¢cantly di¡erent from each other (Student’s
t-test, P6 0.05).
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3.4. Induction of HO-1 after inhibition of TrxR by CDNB
We investigated whether CDNB, an inhibitor of TrxR that
is chemically unrelated to ATG, can elicit HO-1 induction in
cultured liver cells. CDNB alkylates TrxR and irreversibly
inhibits it [17,18]. CDNB is also conjugated with GSH by
various glutathione S-transferase isoenzymes and depletes
GSH through this mechanism [19]. As shown in Fig. 5,
CDNB caused a dose-dependent inhibition of cytosolic
TrxR accompanied by an increase of HO-1 protein expres-
sion. GR activities were not signi¢cantly reduced. Like
ATG, CDNB inhibited TrxR activities in both cytosolic and
mitochondrial fractions of H4IIE lysates (not shown).
CDNB depletes cellular GSH and CDNB-treated H4IIE
cells have low GSH levels. To eliminate GSH depletion as
the cause of HO-1 induction [20], we added graded amounts
of the GSH precursor, N-acetylcysteine (NAC), to the culture
medium to maintain normal GSH concentrations in CDNB-
treated cells. As shown in Fig. 6, CDNB inhibited TrxR and
induced HO-1 even when control GSH levels were maintained
by NAC supplementation. This suggests that CDNB treat-
ment leads to HO-1 induction through a mechanism unrelated
to GSH depletion. TrxR inhibition is likely to be that mech-
anism.
4. Discussion
Earlier work from our group demonstrated that hepatic HO
activity is increased in selenium-de¢cient rats and is further
induced by PB treatment of them [14]. Injection of de¢cient
animals with selenium 6 h before PB treatment blocked the
HO induction, whereas its administration simultaneously with
PB had no e¡ect on induction [4]. This suggested that sele-
nium administration was supporting synthesis of a selenopro-
tein that prevented HO induction. The aim of the present
study was to identify that selenoprotein.
Two selenoproteins, GSHPx-1 and selenoprotein P, were
easily eliminated by the use of animals in which genes for
these proteins had been disrupted. Another approach had to
be taken for TrxR because no mice with a TrxR gene deleted
are available. Attempts to produce mice with the Trx gene
deleted were unsuccessful because the deletion was embryonic
lethal [21]. Thus, production of mice with TrxR genes deleted
may only be possible with tissue-speci¢c deletion techniques.
TrxR is exquisitely sensitive to inhibition by gold com-
pounds [22]. We were able to inhibit it in mouse liver without
inhibiting GSHPx-1 (GSHPx activity) or GSHPx-4 (PH-
Fig. 4. TrxR activity (open circles) and HO-1 protein expression
(solid squares) in 18 000Ug supernatants from H4IIE cells. Cells
were treated with the indicated doses of ATG for 16 h. TrxR activ-
ities are given as means (n=3, error bars indicate S.E.M.). HO-1 ex-
pressions were determined by densitometric evaluation of the respec-
tive Western blots. Symbols indicate means of two independent
experiments (A). A representative blot is shown in B.
Fig. 5. TrxR and GR activities (A) and HO-1 protein expression
(B) measured in 18 000Ug supernatants from H4IIE cells that had
been treated with the indicated doses of CDNB for 4 h. Enzyme ac-
tivities are given as means (n=3, error bars indicate S.E.M.).
Table 2
Overview of antioxidant enzymes inducible by selenium de¢ciency or gold compounds
Enzyme Induced by
Selenium de¢ciency Gold compounds
Q-Glutamyl-cysteine synthetase enzyme activity [3] mRNA [28]
NAD(P)H:quinone reductase enzyme activity [1], mRNA [29] mRNA [28]
Glutathione S-transferase enzyme activity [2] enzyme activity [30,31]
HO-1 enzyme activity [4], protein expression [5],
mRNA [5]
enzyme activity [this study], protein expression
[this study], mRNA [28]
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GSHPx activity) by administering ATG (Fig. 2). Inhibition of
hepatic TrxR in vivo was associated with induction of HO-1
and with further inducibility of HO-1 by PB (Fig. 3). This
behavior of HO-1 is the same as seen in selenium de¢ciency.
Work in the rat hepatoma cell line gave the same e¡ect with
ATG as seen in vivo and demonstrated that CDNB, another
TrxR inhibitor, caused HO-1 induction as well. This strongly
suggests that lack of TrxR, or of an activity dependent on it,
leads to the induction of HO-1.
The thioredoxin enzyme family consists of the TrxRs, the
Trxs, and the enzymes that derive their reducing equivalents
from TrxR through Trx [23]. Most peroxiredoxins fall into
this category. Another of these enzymes, methionine sulfoxide
reductase B, is a selenoprotein [24], and therefore doubly de-
pendent on selenium. Thus, inhibition of TrxR a¡ects many
enzyme activities. One (or more than one) of these TrxR-de-
pendent enzymes is likely to be the enzyme for which HO-1
compensates.
Besides its antioxidant function, the thioredoxin family ful-
¢lls a crucial role in the regulation of redox-sensitive tran-
scription factors, e.g. the DNA-binding activity of AP-1 is
regulated by Trx [25,26] and especially the AP-1-dependent
induction of HO-1 by in£ammatory mediators is facilitated
by Trx [27]. In a previous study, we found increased AP-1
binding activity preceding HO-1 induction in selenium-de¢-
cient rat liver in response to PB [5]. This indicates that Trx-
dependent gene regulation might be the molecular basis for
HO-1 induction by selenium de¢ciency and thus TrxR de¢-
ciency. Several antioxidant enzymes are induced in selenium
de¢ciency. At least four of them are also inducible by anti-
rheumatic gold compounds which function as TrxR inhibitors
(Table 2). It is therefore conceivable that TrxR is the key
selenoprotein associated with the induction of these stress
response genes by dietary selenium de¢ciency.
While the Trx family has been identi¢ed as having a special
relationship with HO-1, further work will be necessary to
identify the family members that are directly involved.
Acknowledgements: This work was supported by Grant MO936/2-1
from the Deutsche Forschungsgemeinschaft (to V.M.) and National
Institutes Of Health Grants ES02497 and ES00267.
References
[1] Reiter, R. and Wendel, A. (1983) Biochem. Pharmacol. 32, 3063^
3067.
[2] Hill, K.E., Burk, R.F. and Lane, J.M. (1987) J. Nutr. 117, 99^
104.
[3] Hill, K.E. and Burk, R.F. (1982) J. Biol. Chem. 257, 10668^
10672.
[4] Correia, M.A. and Burk, R.F. (1978) J. Biol. Chem. 253, 6203^
6210.
[5] Mostert, V., Hill, K.E., Ferris, C.D. and Burk, R.F. (2003) Biol.
Chem. (in press).
[6] Burk, R.F. (1987) Methods Enzymol. 143, 307^313.
[7] Ho, Y.S., Magnenat, J.L., Bronson, R.T., Cao, J., Gargano, M.,
Sugawara, M. and Funk, C.D. (1997) J. Biol. Chem. 272, 16644^
16651.
[8] Hill, K.E., Zhou, J., McMahan, W.J., Motley, A.K., Atkins,
J.F., Gesteland, R.F. and Burk, R.F. (2003) J. Biol. Chem. (in
press).
[9] Correia, M.A. and Schmidt, R. (1975) Biochem. Biophys. Res.
Commun. 65, 1378^1384.
[10] Lawrence, R.A. and Burk, R.F. (1976) Biochem. Biophys. Res.
Commun. 71, 952^958.
[11] Maiorino, M., Gregolin, C. and Ursini, F. (1990) Methods En-
zymol. 186, 449^483.
[12] Carlberg, I. and Mannervik, B. (1975) J. Biol. Chem. 250, 5475^
5480.
[13] Smith, A.D. and Levander, O.A. (2002) Methods Enzymol. 347,
113^121.
[14] Correia, M.A. and Burk, R.F. (1976) Arch. Biochem. Biophys.
177, 642^644.
[15] Gromer, S., Arscott, L.D., Williams Jr., C.H., Schirmer, R.H.
and Becker, K. (1998) J. Biol. Chem. 273, 20096^20101.
[16] Sun, Q.-A., Wu, Y., Zappacosta, F., Jeang, K.-T., Lee, B.J.,
Hat¢eld, D.L. and Gladyshev, V.N. (1999) J. Biol. Chem. 274,
24522^24530.
[17] Arner, E.S., Bjornstedt, M. and Holmgren, A. (1995) J. Biol.
Chem. 270, 3479^3482.
[18] Nordberg, J., Zhong, L., Holmgren, A. and Arner, E.S. (1998)
J. Biol. Chem. 273, 10835^10842.
[19] Awasthi, Y.C., Garg, H.S., Dao, D.D., Partridge, C.A. and Sri-
vastava, S.K. (1981) Blood 58, 733^738.
[20] Saunders, E.L., Maines, M.D., Meredith, M.J. and Freeman,
M.L. (1991) Arch. Biochem. Biophys. 288, 368^373.
[21] Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama,
T., Yodoi, J. and Taketo, M.M. (1996) Dev. Biol. 178, 179^185.
[22] Smith, A.D., Guidry, C.A., Morris, V.C. and Levander, O.A.
(1999) J. Nutr. 129, 194^198.
[23] Arner, E.S.J. and Holmgren, A. (2000) Eur. J. Biochem. 267,
6102^6109.
[24] Kryukov, G.V., Kumar, R.A., Koc, A., Sun, Z. and Gladyshev,
V.N. (2002) Proc. Natl. Acad. Sci. USA 99, 4245^4250.
[25] Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K. and
Yodoi, J. (1997) Proc. Natl. Acad. Sci. USA 94, 3633^3638.
[26] Karimpour, S., Lou, J., Lin, L.L., Rene, L.M., Lagunas, L., Ma,
X., Karra, S., Bradbury, C.M., Markovina, S., Goswami, P.C.,
Spitz, D.R., Hirota, K., Kalvakolanu, D.V., Yodoi, J. and Gius,
D. (2002) Oncogene 21, 6317^6327.
[27] Wiesel, P., Foster, L.C., Pellacani, A., Layne, M.D., Hsieh, C.
-M., Huggins, G.S., Strauss, P., Yet, S.-F. and Perrella, M.A.
(2000) J. Biol. Chem. 275, 24840^24846.
[28] Kataoka, K., Handa, H. and Nishizawa, M. (2001) J. Biol.
Chem. 276, 34074^34081.
[29] Fischer, A., Pallauf, J., Gohil, K., Weber, S.U., Packer, L. and
Rimbach, G. (2001) Biochem. Biophys. Res. Commun. 285, 470^
475.
[30] Dillard, C.J., Hu, M.L. and Tappel, A.L. (1987) Chem. Biol.
Interact. 64, 103^114.
[31] Kim, Y.S. and Combs Jr., G.F. (1993) Biol. Trace Elem. Res. 37,
165^177.
Fig. 6. TrxR activities and GSH levels in 18 000Ug supernatants
from H4IIE cells (A). Cells were treated with 20 WM of CDNB for
4 h in the presence of the indicated concentrations of NAC. Values
are given as means (n=3, error bars indicate S.E.M.). Representa-
tive HO-1 protein expression is shown in B.
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